✦ LIBER ✦

A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL OF A NOVEL, AUTOLOGOUS, THERAPEUTIC VACCINE (VITESPEN) VS. OBSERVATION AS ADJUVANT THERAPY IN PATIENTS AT HIGH RISK OF RECURRENCE AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA

✍ Scribed by P. Mulders; C.G. Wood; S. Gorelov; K. Krajka; S. Mikhailov; A. Gorelov; S.D. Fossa; P. Champagne; P.K. Srivastava; B. Escudier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-19.13: A multicenter, randomized, pha

✍ C. Wood; B. Escudier; L. Lacombe; A. Hoos; R. Gupta; R. Flanigan; R. Figlin; P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

POD-6.02: A Multicenter, Randomized, Pha

✍ S. Tanguay; C. Wood; R. Bukowski; P. Champagne; P. Srivastava; B. Escudier; L. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

An adjuvant autologous therapeutic vacci

✍ Christopher Wood; Pramod Srivastava; Ronald Bukowski; Louis Lacombe; Andrei I Go 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 312 KB

Autologous tumour cell vaccine may reduc

✍ Chris Coppin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 234 KB